Creatinine to Cystatin-C Ratio in Renal Cell Carcinoma: A Clinically Pragmatic Prognostic Factor and Sarcopenia Biomarker.

Benjamin N Schmeusser, Henry Biermann, Edouard H Nicaise,Adil A Ali,Dattatraya H Patil,Eric Midenberg,Talia Helman,Manuel Armas-Phan,Reza Nabavizadeh,Shreyas S Joshi,Vikram M Narayan,Mehmet A Bilen,Sarah P Psutka,Kenneth Ogan,Viraj A Master

The oncologist（2023）

引用 0|浏览13

暂无评分

摘要

Lower Cr/Cys-C is associated with inferior oncologic outcomes in RCC and, pending validation, may have utility as a serum biomarker for the presence of sarcopenia in patients with RCC treated with nephrectomy.

查看译文

关键词

renal cell carcinoma (RCC), nephrectomy, survival, sarcopenia, body composition, biomarker

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要